key: cord-0916344-ghgz404p authors: King, Jessica J C; Powell-Jackson, Timothy; Makungu, Christina; Spieker, Nicole; Risha, Peter; Mkopi, Abdallah; Goodman, Catherine title: Effect of a multifaceted intervention to improve clinical quality of care through stepwise certification (SafeCare) in health-care facilities in Tanzania: a cluster-randomised controlled trial date: 2021-08-04 journal: Lancet Glob Health DOI: 10.1016/s2214-109x(21)00228-x sha: e8036a4d45311c5a5bf7081a36b32146f5f6cc2b doc_id: 916344 cord_uid: ghgz404p BACKGROUND: Quality of care is consistently shown to be inadequate in health-care settings in many low-income and middle-income countries, including in private facilities, which are rapidly growing in number but often do not have effective quality stewardship mechanisms. The SafeCare programme aims to address this gap in quality of care, using a standards-based approach adapted to low-resource settings, involving assessments, mentoring, training, and access to loans, to improve clinical quality and facility business performance. We assessed the effect of the SafeCare programme on quality of patient care in faith-based and private for-profit facilities in Tanzania. METHODS: In this cluster-randomised controlled trial, health facilities were eligible if they were dispensaries, health centres, or hospitals in the faith-based or private for-profit sectors in Tanzania. We randomly assigned facilities (1:1) using computer-generated stratified randomisation to receive the full SafeCare package (intervention) or an assessment only (control). Implementing staff and participants were masked to outcome measurement and the primary outcomes were measured by fieldworkers who had no knowledge of the study group allocation. The primary outcomes were health worker compliance with infection prevention and control (IPC) practices as measured by observation of provider–patient interactions, and correct case management of undercover standardised patients at endline (after a minimum of 18 months). Analyses were by modified intention to treat. The trial is registered with ISRCTN, ISRCTN93644888. FINDINGS: Between March 7 and Nov 30, 2016, we enrolled and randomly assigned 237 health facilities to the intervention (n=118) or control (n=119). Nine facilities (seven intervention facilities and two control facilities) closed during the trial and were not included in the analysis. We observed 29 608 IPC indications in 5425 provider–patient interactions between Feb 7 and April 5, 2018. Health facilities received visits from 909 standardised patients between May 3 and June 12, 2018. Intervention facilities had a 4·4 percentage point (95% CI 0·9–7·7; p=0.015) higher mean SafeCare standards assessment score at endline than control facilities. However, there was no evidence of a difference in clinical quality between intervention and control groups at endline. Compliance with IPC practices was observed in 8181 (56·9%) of 14 366 indications in intervention facilities and 8336 (54·7%) of 15 242 indications in control facilities (absolute difference 2·2 percentage points, 95% CI −0·2 to −4·7; p=0·071). Correct management occurred in 120 (27·0%) of 444 standardised patients in the intervention group and in 136 (29·2%) of 465 in the control group (absolute difference −2·8 percentage points, 95% CI −8·6 to −3·1; p=0·36). INTERPRETATION: SafeCare did not improve clinical quality as assessed by compliance with IPC practices and correct case management. The absence of effect on clinical quality could reflect a combination of insufficient intervention intensity, insufficient links between structural quality and care processes, scarcity of resources for quality improvement, and inadequate financial and regulatory incentives for improvement. FUNDING: UK Health Systems Research Initiative (Medical Research Council, Economic and Social Research Council, UK Department for International Development, Global Challenges Research Fund, and Wellcome Trust). Appendix A: Study sample Selection of study facilities Eligible facilities were dispensaries and health centres which are members of APHFTA (the Association of Private Health Facilities in Tanzania which represents mainly for-profit facilities), and dispensaries, health centres and hospitals which were members of CSSC (the Christian Social Services Commission which represents most mission facilities). Facilities were ineligible if they refused consent, provided specific services only (e.g. mental health or maternity), or were tertiary hospitals. Facilities were recruited from the Northern, Eastern, Central, Southern and Southern Highlands zones of Tanzania (Lake Zone was excluded because SafeCare had been rolled out there prior to study commencement). The selection of study facilities was based on an initial long list of 975 private health facilities provided by the implementing partners (462 APHFTA member facilities and 513 CSSC member facilities). We then worked with the implementing partners to select a sampling frame of 280 facilities that potentially met study eligibility criteria. For the CSSC facilities, we selected a random sample of 124 health facilities, stratified by facility type (dispensary, health centre, hospital). For the APHFTA facilities, we were given a list of 156 health facilities that included dispensaries and health centres. Because of the sampling strategy, we do not claim that the study sample is representative of the broader population of health facilities in the study zones. The partner organisations approached the 280 potentially eligible facilities to confirm eligibility, carry out sensitisation and obtain written informed consent to participate. Of these, 43 declined to participate in the study or were found to be ineligible, such that 237 facilities were recruited at baseline. Facilities were informed at sensitisation that there would be an endline assessment as well as other data collection for both intervention and control arms in order to measure the impact of the SafeCare package. 1. Evidence for treatment: is there clinical evidence (preferably national standard treatment guidelines) by which to define correct treatment or management? This was a prerequisite for consideration. 2. Clinical and public health significance: does recognition and correct treatment of the condition have an important public health role, or is it a serious clinical emergency? 3. Frequency in study facilities: is the condition commonly enough seen in study facilities that correct recognition and treatment is feasible, and it will not arouse suspicion? 4. Risk to fieldworkers and ethical considerations: will the case necessitate practices which expose the fieldworker to hospital-acquired infection, invasive examinations or a life-changing diagnosis? 5. Falsifiability of symptom and ease of diagnoses: can the symptoms be easily falsified by fieldworkers and will the provider be able to make a diagnosis on the basis of those symptoms during a single consultation with limited laboratory testing? 6. Universal applicability: can the condition be diagnosed or treated, or an appropriate referral made, at all facilities in the SafeCare study? The assessment by the study team is summarised in Table B1 below. As a result, four conditions were selected as most appropriate for SPs in our study: upper respiratory tract infection (URTI), suspected malaria/non-malarial febrile illness, TB and asthma. Facilities were asked to give consent to covert SP visits during the first (overt) phase of fieldwork, but not be given any further details. In order to minimise the risk of SP detection, details of SP cases and their correct management were not be shared with the PharmAccess Tanzania office, or implementing partners APHFTA and CSSC. Expected management covers the taking of medical history, giving correct treatment or referral, and giving appropriate advice. Expected management is based on Tanzanian standard treatment guidelines 3 , MAQARI SP manual 2 and Heymann (2015) 4 . The expected management for each case is given in Table B2 below. As a primary outcome of quality of care, we define a binary indicator of 'correct management' for each SP case. To fulfil correct management, the provider must carry out all 'actions required' and no 'actions precluding' as set out in Table B3 . All fieldwork contains inherent risks, but SP studies expose fieldworkers to additional risks by asking them to pose as real patients. SP cases and training must be designed to minimise these risks. The major risks identified by the study team and MAQARI SP manual 2 , and steps taken to reduce them, are detailed below. 1. Exposure to airborne pathogens in facility. There is little that can be done to reduce exposure of SPs to respiratory pathogens when waiting inside a facility. More serious respiratory infections, such as TB, are not treated in small clinics, and are treated in separate outdoor clinics in larger facilities. It is therefore thought that the risk of an SP contracting a serious respiratory infection from this work is minimal. This study was conducted in 2018 before the emergence of COVID-19. 2. Exposure to surface pathogens in facility. During training, SPs were educated about the pathogens that remain on surfaces inside facilities. They were informed of the importance of hand hygiene after the end of the facility visit, and supplied with alcohol hand gel. 3. Exposure to pathogens on thermometers. SPs were trained to avoid having temperature taken with an unsterilized oral thermometer. Training included: a. Recognition of when thermometer may not have been sterilized b. Asking provider whether thermometer has been sterilized c. Asking provider to use sterilized thermometer/sterilize thermometer before use d. Refusing to have temperature taken orally if thermometer not sterile e. Revealing identity as SP if refusal not accepted 4. Exposure to pathogens through injections. SPs were trained to avoid all injections, IV fluids and other parenteral administration of medications. Training included: a. Recognition of terms provider may use to indicate they plan to give SP injection b. Recognition of provider actions which indicate imminent injection (e.g. preparing needle) c. Refusal of injections on grounds of extreme needle phobia "I cannot have injections, the last time I received an injection I lost consciousness" d. Refusal of injections on grounds of cost "I do not have the money to pay for an injection with me today, I don't want it" e. Refusal of injections on grounds of fasting "I am fasting so I may not have an injection" f. Revealing identity as SP if refusal not accepted 5. Exposure to pathogens through blood draws. SP cases have been chosen to minimise likelihood of blood tests, with the exception of the malaria case, which requires a finger-prick blood sample. SPs were trained to avoid having blood drawn except from the fingertip with a single-use, sterile lancet for a malaria test or blood glucose test. Training included: a. Asking provider whether a diagnostic test requires blood to be taken b. Asking provider where blood will be taken from c. Recognising a single-use sterile lancet d. Refusal of blood draw on grounds of extreme needle phobia "I cannot have injections, the last time I received an injection I lost consciousness" e. Refusal of diagnostic tests on grounds of cost "I cannot do these tests; I can't pay for them" f. Refusal of diagnostic tests on grounds of inconvenience "I cannot stay and have these tests, I have to meet with someone soon" g. Leaving the facility and paying fees without having diagnostic tests if refusal not accepted h. Revealing identity as SP if refusal not accepted 6. Unnecessary exposure to ionising radiation. SPs were trained to avoid all X-rays. X-rays are only likely to be offered to TB SPs, and only 37 of 237 study facilities can offer X-ray imaging, so this risk existed in a small number of cases. If offered, SPs refused on grounds of cost. 7. Administration of unnecessary/harmful medications. SPs were trained to avoid all medications: a. Parenteral administration was avoided as outlined above (4) b. SPs were trained to give all dispensed medications to supervisor as soon as reasonably possible, and that they must not under any circumstances take medications. The medications were stored and returned to study team for quality control testing c. If provider offers oral medication in facility, SP was trained to refuse on grounds of fasting, and say that they can take it in the evening. d. If fasting will not be believed, refused on grounds of cost e. SPs must reveal identity rather than take any medication 8. Invasive physical examinations. SP cases have been chosen to minimise the likelihood of invasive physical exams. SPs were trained to refuse pelvic/genital exams and any other examination or procedure they do not feel comfortable with, and to reveal their identity as an SP as a last resort if necessary. 9. Admission to facility. SPs were trained to avoid being admitted to the facility as an inpatient. They refused to be admitted on grounds of inconvenience, saying they need to return to where they live and will seek medical attention there. If this explanation was not accepted, they were to reveal their identity as an SP. 10. Diagnosis of previously undetected condition. There is a risk that SPs may be diagnosed with a genuine medical condition during the course of their work, as a direct result of investigations carried out in study facilities. SP cases have been designed to minimise this risk. SPs were only be recruited if they self-report good health and did not report any underlying conditions. Specific scenarios are outlined below: a. HIV: No SP will be diagnosed as blood cannot be taken except for finger-prick samples for malaria or glucose. b. Malaria: If SP tests positive for malaria, they must report this to the supervisor and take a second RDT. If this is also positive the SP/supervisor should purchase AL for treatment. c. Hypertension: SPs are likely to have blood pressure measured frequently during the study period and may be informed they are hypertensive. 11. Abuse/harassment at facility due to detection of SP. During the first (overt) round of field work, facilities were informed of the use of SPs in the study and asked to give their consent. SPs were only be sent to facilities where consent has been given for the use of SPs. The facility was asked to ensure that the manager, duty manager or supervisor has been informed of SPs. A letter was be given to facilities explaining the use of SPs, to be put on file in the facility along with a copy of the ethical approval. If the identity of an SP is revealed, or the SP needs to reveal their identity to avoid harm they should: a. Explain that they are a fieldworker from the SafeCare/LSHTM/IHI study b. Thank the provider for their time, pay any outstanding fees and leave the facility c. If challenged, show copies of letter and ethical approval, and tell provider the facility should also have them on file d. Provide the contact details of a member of the study team if the provider has further queries SPs must give all medications which are dispensed to them to their supervisor after they have completed details on exit questionnaire. The supervisor checked medication against completed questionnaire to ensure that the correct number of items has been returned. All medications from that visit were sealed in a plastic bag and labelled with the date, facility name and code, fieldworker name and SP case. The supervisor was responsible for the safe-keeping of medications until the team returned to IHI, or a researcher visited the field and collects the medication. Supervisor was in charge of petty cash book. At the beginning of each working day/week, the supervisor made sure each SP has enough cash to pay for all planned facility visits (TSH 25,000 for APHFTA facilities and TSH 15,000 for CSSC facilities), and recorded any petty cash that needed to be dispensed in advance. Total fees paid were recorded in petty cash book as per SP questionnaire for each facility visit. SP was reimbursed for fees paid, minus advance. All facilities were followed up to assess whether an SP visit was detected or suspected. Follow-up was conducted by telephone. -Record number(s) provided in SA+ and print on facility consent form. -Ask owner/provider to confirm that this is the correct number when consenting for fieldwork, or to provide an alternative number (or email address if this is not possible). -If facility/owner is not reachable through number provided in SA+ or at facility, ask APHFTA/CSSC to provide details or make contact on our behalf. -After all four SP visits have been confirmed as completed by the supervisor, wait at least one week until making follow-up call. -The maximum time between completion of SP visits and follow-up call should be four weeks. -We should not confirm with providers whether their suspicions are correct, or give details of SP case types. SP fieldwork will be ongoing for three months and we need to avoid the risk of information being passed to other facilities. Numbers: We planned to employ 16 SPs organised into four teams of four, and one supervisor for each team. We aimed to recruit and train 30 fieldworkers to allow for attrition and selection. Person characteristics and appearance: All scenarios can be acted by men or women in their twenties or thirties. Health: We aimed to recruit SPs who are in good health to avoid other complaints misleading providers. SPs were be asked if they have been diagnosed with asthma, TB or any serious chronic condition in the past, and were excluded if it was decided that the condition will put them at risk or mislead providers during the SP scenario. Background: SPs should not have a clinical background. The main purpose of the SP training was to teach SPs about the case they are meant to portray, and how they should go about doing this. SPs were told about the conditions they are acting, and the symptoms the patient would and would not have. SPs were trained to only give information that is asked for by a care provider, and not to deliberately give more information to 'help' the provider along the way to a diagnosis. SPs practised coming up with answers for unexpected questions, so that they are prepared to give an answer if a provider asks about a symptom or lifestyle factor that the study team did not anticipate when producing scripts. Background story Time during training was dedicated to developing background stories for the SP characters. SPs were be trained to portray people from a lower middle class demographic group, to match the type of clients expected at small private providers, and were told what job and education level their character has. SPs were trained to dress according to this character, and to adapt their dress to different areas of the country where necessary. SPs were given examples of how to explain their attendance at a facility where they are not recognised, and trained to respond to questions about where they are staying and where they are from. The basic backstory, which can be adapted according to SP and setting, is that the SP is visiting to buy cash crops or sell second hand goods. This allows SPs to explain why they are in the area without requiring them to have local knowledge. SPs worked in groups to develop the 'personality' of their SP, working out how their character would respond to different behaviours from providers. This reduced heterogeneity in the portrayal of SP cases across different fieldworkers. Role play SPs practised acting their cases in pairs, taking turns to play provider and SP. SPs were given a number of scenarios to allow them to practise their response in different circumstances, for example, refusing an injection, or when asked about a symptom that isn't mentioned in the SP script. Members of the study team also acted as 'provider' to check the progress and portrayal of SPs. Exit questionnaire SPs practised completing the exit questionnaire when role-playing SP scenarios. Members of the study team validated exit questionnaires during roleplay for each SP, observing the interaction and also completing the questionnaire, then feedbacking to the SP on any discrepancies. SPs were taught about sources of infection in health facilities and other risks to their safety, and trained to recognise and anticipate when they might be at risk (see Harm minimisation section). Emphasis was placed on refusing care assertively, and revealing status as an SP rather than accepting any potentially harmful practice. In the final stages of training, SPs had a 'dress rehearsal' at a local facility. The study team approached local facilities that were not part of the study and ask for consent to send SPs to them for training. SPs carried out visits to these facilities in pairs, with a second fieldworker posing as a partner or relative to give feedback, following procedures exactly as they should for fieldwork, including completing the exit questionnaire. A second dress rehearsal was arranged if necessary. Questionnaire completion SP data collection was a self-administered smartphone questionnaire immediately after the end of the interaction, verified by the supervisor at the end of the day. SPs were trained to find a suitable location to complete the questionnaire after leaving the facility. Facilities in town: SPs should walk to the facility. If the facility is a long distance from accommodation, public transportation can be used, or SP can be dropped by an IHI vehicle at least 500m away and approach on foot. Use of IHI vehicles should be limited in small communities to avoid drawing attention to the presence of fieldworkers. Facilities outside of town: If facility can be reached by bus from the nearest town, SP should travel this way. If not feasible, SP should take taxi (if available at reasonable cost) or be transported in IHI car. When IHI cars are used for transportation to facility, SPs should be dropped at least 500m from facility and approach on foot. A pick-up point should be agreed at this time. SPs were in four teams of four, each with one supervisor, giving a total team size of eight. Teams visited different regions of the country. Each team had one male and one female SPs trained to portray two of the four scenarios, who were be randomly assigned to facilities. Assignment to facilities was stratified as per recruitment. Visits were made 10am-4pm, to avoid the busiest outpatient clinic times (typically early morning and evening), and night hours where a reduced service operates and some facilities are closed. Visits were planned for Saturday and Sunday only if a full service runs on those days. The visiting time is left flexible between these hours to allow multiple visits per day in towns and cities, and to allow for travel time to remote facilities. Fieldworkers observed provider-patient interactions for six hours in each facility: three hours in the consultation rooms, one and a half hours in the laboratory, and one and a half hours in the injection or dressing room. All patients were eligible if they or their adult caretaker gave verbal informed consent. Individuals below 18 years of age were excluded if they were not accompanied by an adult caretaker To minimise bias, fieldworkers were coached to observe discreetly from the corner of the room, limit any interaction with either provider or patient, and not disclose that observations were focused on IPC practices Fieldworkers recorded every indication and action on a paper version of the IPC tool. The data were double entered in Dar es Salaam on tablets using ODK Collect v.1.12.1. Providers were asked for written consent to be observed prior to commencing observation, but were not shown the tool, or told that observation was specifically for the purpose of measuring IPC compliance. PharmAccess staff were informed that IPC compliance would be measured as part of the evaluation, but wwere not given details on how this would be done or access to any of the study tools. Before touching a patient Provider washed hands with soap or used alcohol hand rub and did not dry hands on reused towel or clothes. After touching a patient Before a clean/aseptic procedure The SafeCare score uses data from the SafeCare assessment survey, full details of which can be found at https://www.safe-care.org/who-we-are/safecare-standards/ . Facilties were assessed on 170 (for a basic assessment) or 680 (for an advanced assessment) standards. Each standard was recorded as either non-compliant, partially compliant or fully compliant, aided by a detailed descriptor used to evaluate each practice. We coded "non-compliant" as 0, "partially compliant" as 0.5, and "fully compliant" as 1, and took the unweighted average across the 170 basic standards (applicable in both basic and adavancd assessments) to generate a score. Patient volume Mean monthly patient volume was calculated on the basis of numbers of visits reported for the last three completed months. Fieldworkers were trained to record figures directly from facility records. Data was collected separately for outpatient curative visits, outpatient clinic visits, inpatient admissions (per admission not night stayed) and deliveries. Care which is always free (antenatal visits, postnatal visits, immunisations and child growth checks) was excluded. Mean monthly income was calculated on the basis of revenue reported for the last three completed months. Fieldworkers were trained to record figures directly from facility records. Data was collected separately for cash, mobile money, invoices to insurances companies (on the basis of the last three months for which all invoices had been sent, but payment of the invoices was not required) and government transfers (only cash and not in-kind transfers were included) Experience of care score The patient exit survey was used to measure patient satisfaction with the experience of care. We developed a set of 21 questions based on existing tools, including the Hospital Consumer Assessment of HealthCare Providers and Systems done in the US. The questions covered experiences and satisfaction across various dimensions, such as the waiting time, degree of privacy, and ability of the clinician to communicate well. Table B4 provides more details. Fieldworkers read out 21 statements and patients were asked to say whether they agreed, disagreed or neither agreed or disagreed. In accordance with best practice, we used both positively and negatively framed questions to address the upward bias that comes with using all positive questions. We conducted face-to-face exit interviews with patients as they were about to leave the health facility. A convenience sampling approach was used, with the next available patient approached when a previous interview was finished. Patients were eligible if they had received curative outpatient care (therefore excluding routine visits for growth checks, immunisations or antenatal care) and had completed their visit to the facility (including collecting prescribed treatments and making payments). We sought to interview up to eight patients in each health facility. During interview the fieldworkers entered the data digitally into tablets using ODK Collect v.1.12.1. To generate a summary score, we first assigned a value of 1 to "agree", 0.5 to "neutral" and 0 to "disagree". For statements that were negatively framed, such as "the clinician did not listen carefully to me", we reverse scored the responses. After normalizing the responses to each question on a 0 to 1 scale, we took the unweighted average across the 21 items. For five of the 21 statements, respondents were permitted to give a "not applicable" response. This response is coded as missing when we take the unweighted average across the items. The summary score is interpreted as the proportion of the maximum satisfaction with the experience of care obtainable. The clinician was thorough in investigating my symptoms 4 The clinician did not listen carefully to me 5 The clinician gave me sufficient information about my illness/condition and care 6 The clinician explained things to me in a way that was easy to understand A key part of the SafeCare intervention is the mentoring visits made by the quality advisors to health facilities. They are described as quality improvement plan (QIP) progress visits, as the main aim is for the advisor to monitor the facility's progress towards implementing its QIP. The target frequency for visits is approximately once per quarter, which can be translated into at least five visits during the study period for each intervention facility. The distribution of number of visits received by implementing partner is shown in Figure C1 . The mean number of visits received was 3.1 overall, 4.0 for APHFTA facilities and 2.2 for CSSC facilities (p<0.0001). Training sessions Training sessions could be delivered at external venues attended by multiple facilities, or on-site at a given facility, though informal training during mentoring visits was generally not recorded. It was expected that each facility receives at least two trainings during the intervention, one on quality and one on business. The mean number of trainings attended was 0.6 overall, 1.1 for APHFTA facilities and 0.1 for CSSC facilities. Details are given in Table C1 below. Loans Loans, provided by commercial banks but guaranteed by the Medical Credit Fund (MCF), were part of the intervention package but in practice available to both control and intervention facilities. The details of the four loans disbursed in the study period (two to intervention facilities, two to control facilities) are given below. Hawthorne effect sensitivity analysis Directly observing health workers gives rise to the possibility that they alter their behaviour. The specific concern in our study is that health workers may have temporarily increased IPC compliance when they were observed by the research team, above their usual level of performance. We assessed the presence of a Hawthorne effect by examining whether compliance with IPC practices was associated with order number of patients observed. The general idea behind the sensitivity analysis is that, if there was a Hawthorne effect, health workers would eventually get used to being observed and IPC compliance would revert to a lower level closer to actual practice. In the data this would show up as a negative association between IPC compliance and order of patient observation. While evidence of a Hawthorne effect has implications for measurement, it is only a concern for the integrity of the trial if the association between compliance with IPC practices and the order number of patients observed differs by treatment arm. We analysed data at the level of patient observation. The dependent variable was IPC compliance, defined as the proportion of indications for which the health worker complied with the correct action. The independent variable of interest was the order number of patients observed for each health worker. Since there were observations with an order number of patients observed above 15, we recoded these as "15 or more" in the descriptive figures. Each health worker was observed for an average of 5.0 patient interactions (SD 4.3). To test for the presence of a Hawthorne effect, we ran four OLS regression models. Model 1 included no other covariates. Model 2 included an indicator for each IPC indication. Model 3 additionally controlled for health worker (age, sex, cadre) and facility (level, ownership, location) characteristics. Model 4 replaced the facility and health worker characteristics with health worker fixed effects, and is our preferred model. To test for whether any association between compliance with IPC practices and the order number of patients observed differs by treatment arm, we ran equivalent OLS regressions, additionally including the treatment dummy, and an interaction between the treatment dummy and the order number of patients observed. The coefficient on the interaction is the coefficient of interest. Figure D1 shows IPC compliance by order of patient observation in the treatment and control groups separately. Two results are worth noting. First, there is an increasing trend: IPC compliance tends to be better at higher order number of patients observed but the trend is clearly very modest. It is important to note that Figure D1 presents descriptive data and the relationship is likely confounded by the fact that more patients (per health worker) were observed in the laboratory where IPC compliance was consistently high by the very nature of the IPC indications triggered when drawing blood. Second, the relationship between IPC compliance and order number of patients observed is very similar between treatment and control. Table D6 reports the first set of regression results. Across the four models, there is no consistent direction in the association and the coefficient is small in magnitude in all instances. In the unadjusted model, the coefficient is positive (p=0.011), mirroring the pattern shown in Figure D1 . In model 4 -our preferred model with indicators for each indications and health worker fixed effectsthe coefficient is negative and insignificant (p=0.862). Table D7 includes an interaction to test whether the linear trend differs between treatment and control. In the unadjusted model, the trend in the treatment group is not significantly different from that of the control group (p=0.627). This result is confirmed when we include health worker fixed effects in model 4 (p=0.182). Notes: Table shows Detais of the detection survey are given in the SP protocol in Appendix B. Interviews were completed with 225 facilities representing 901 visits. A visit was coded as a confirmed detection if the facility reported receiving an SP visit and gave the name used by the SP. Possible detection was coded if the facility gave details which matched the visit (symptoms, gender, approximate age or date) but not the name. Visits were categorised as not detected if the facility did not report any suspicion of having an SP visit, or reported suspicions which did not match the details of the actual SP visits. Results of the detection survey are given in Table D8 . SP results excluding detected SPs are given in Table D9 . Odds ratio Additional quality support ¹Facilities were asked whether they were part the following programmes, or any other programme to improve quality or increase scope of services: Familia/Population Services International, Blue Star/Marie Stopes International, Trust/DKT, Kaizen/5S, Afya Microfinance, and Results Based Financing. Data was reshaped wide to long to give three values per facility for each outcome. Estimates and p values are from a linear regression model controlling for study strata, clustered at the facility to account for the multiple observations per facility. Use of standardised patients to assess antibiotic dispensing for tuberculosis by pharmacies in urban India: a cross-sectional study. The Lancet Infectious Diseases Standardized patients and the measurement of rural healthcare quality: Field guide, manual and sample instruments: MAQARI United Republic of Tanzania: Standard treament guidelines and essential medicines list. 4th ed: Ministry of Health and Social Welfare Control of communicable diseases manual Table D11: IPC compliance (propotion of IPC indications with corresponding compliant action